Forbes contributors publish independent expert analyses and insights. I write about the intersection of business and public affairs. That the proliferation of generics has driven down total costs is ...

According to a regulation by the top medical body, the doctors will have to prescribe generic drugs to patients, or else they will be penalised even if their license to practice may also be suspended ...

Generic drug companies in the U.S. could face an uphill — and costly — legal battle after a new lawsuit filed last week resurfaced collusion allegations. On Friday, a subsidiary of UnitedHealth, the ...

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes. The 30th anniversary of the Hatch-Waxman Act in September generated widespread ...

The high cost of medicines in India is making treatment unaffordable for many, especially the poor and middle class The proposal to mandate the prescription of generic medicines raises concerns about ...

GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a generic drug. Teva said that its generic version of the drug is expected to be available in the fourth ...

FDA funds research to further development of innovative generics, while working to address review and approval issues. Generic drugs have become the mainstay of pharmaceutical therapy, accounting for ...

A 2017 report by Evaluate Pharma estimated that this year, $17 billion in worldwide sales are at risk due to patent expirations. By contrast, last year, $41 billion in sales were at risk, and ...

Shares of Teva Pharmaceutical Industries Limited TEVA fell almost 15% on May 13 following media reports of an antitrust lawsuit filed by 44 states against the company and several other generic ...